SCHEMBL134420

SCHEMBL134420

c1ccc2c(c1)[N]SN2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11622731 0.65 MEN1 (0.40)
SCHEMBL30600357 0.64 GAA (0.36)
SCHEMBL9935222 0.62
SCHEMBL11884871 0.62 LMNA (0.34)
SCHEMBL496558 0.62
SCHEMBL38532 0.62
SCHEMBL1272340 0.61
SCHEMBL240371 0.61 MAPT (0.43)
SCHEMBL13819803 0.61 MAPT (0.43)
SCHEMBL21170617 0.61 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3788 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118290776-A Preparation method of conjugated polymer nanoparticles with ultra-small particle size 中国科学院化学研究所 2024-07-05 CN claimed
US-12018030-B2 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors VALO HEALTH, INC. (US) 2024-06-25 US claimed
US-11987588-B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2024-05-21 US claimed
US-20240051985-A1 METTL3 MODULATORS ACCENT THERAPEUTICS INC (US) 2024-02-15 US claimed
EP-4295910-A2 METHODS FOR TREATING MULTIPLE SCLEROSIS USING PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK INHIBITORY ACTIVITY Merck Patent GmbH (DE) 2023-12-27 EP claimed
US-11739071-B2 Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors VALO HEALTH, INC. (US) 2023-08-29 US claimed
EP-4229067-A1 METTL3 MODULATORS Accent Therapeutics, Inc. (US) 2023-08-23 EP claimed
WO-2023150526-A1 COMPETITIVE AND NONCOMPETITIVE OCTAHYDROCYCLOPENTA[C]PYRROLE INHIBITORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M5 VANDERBILT UNIVERSITY (US) 2023-08-10 WO claimed
EP-3720858-B1 MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO ARENA PHARM INC (US) 2023-06-07 EP claimed
US-20230157996-A1 SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD AND USE THEREOF Shenzhen Bay Laboratory (CN) 2023-05-25 US claimed
US-4879384-A CYCLIC THIAALKANONE DIOXIDE AND UNSATURATED AMINE ESTER ORTHO PHARMACEUTICAL CORPORATION (US) 1989-11-07 US claimed
US-4845225-A CARDIOVASCULAR, ANTIASTHMATIC AND ANTIBRONCHOCONSTRICTOR AGENTS ORTHO PHARMACEUTICAL CORPORATION (US) 1989-07-04 US claimed
US-4777167-A CALCIUM CHANNEL ANTAGONIST, ANTICOAGULANTS, ANTIASTHMATIC, BRONCHODILATOR AGENTS ORTHO PHARMACEUTICAL CORPORATION (US) 1988-10-11 US claimed
US-4705785-A Substituted thiacycloalkeno (3,2-b) pyridines and pharmaceutical compositions and method of use ORTHO PHARMACEUTICAL CORPORATION (US) 1987-11-10 US claimed
EP-0241281-A2 Substituted thiacycloalkeno [3,2-b] pyridines, methods of preparation, compositions and method of use ORTHO PHARMACEUTICAL CORPORATION (US) 1987-10-14 EP claimed
EP-0222702-A2 Basic carbonyl derivatives CIBA-GEIGY AG (CH) 1987-05-20 EP claimed
EP-0214094-A1 1,4-Dihydropyridine derivatives CIBA-GEIGY AG (CH) 1987-03-11 EP claimed
EP-0174654-A2 Carbonyl derivatives CIBA-GEIGY AG (CH) 1986-03-19 EP claimed
EP-0174653-A2 Phenylalkyl derivatives CIBA-GEIGY AG (CH) 1986-03-19 EP claimed
US-4113867-A ANTHELMINTICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1978-09-12 US claimed